Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaibhav Mundra

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Plos One|November 9, 2013
Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantationVaibhav Mundra, Hao Wu, Ram I Mahato
Pharmaceutical Research|November 20, 2013
Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosisVirender Kumar, Vaibhav Mundra, Ram I Mahato
Nanomedicine (London, England)|August 6, 2015
Nanoparticle-mediated drug delivery for treating melanomaVaibhav Mundra, Wei Li, Ram I Mahato
Molecular Pharmaceutics|December 11, 2012
Mesenchymal stem cell-based therapyVaibhav Mundra, Ivan C Gerling, Ram I Mahato
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 21, 2015
Micellar formulation of indocyanine green for phototherapy of melanomaVaibhav Mundra, Yang Peng, Sandeep Rana, et al.
Clinical Pharmacology in Drug Development|September 3, 2025
Relative Bioavailability, Food Effect, and Bioequivalence Studies to Assess a New Zanubrutinib 160-mg Tablet: Results From 2 Phase 1 Studies in Healthy VolunteersBilal Tariq, Chester Lin, Vaibhav Mundra, et al.
Theranostics|August 22, 2018
Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing miceVirender Kumar, Vaibhav Mundra, Yang Peng, et al.
Drug Delivery and Translational Research|May 1, 2015
Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanomaVaibhav Mundra, Yang Peng, Virender Kumar, et al.
Pharmaceutical Research|October 12, 2012
Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agentVaibhav Mundra, Yan Lu, Michael Danquah, et al.
Journal of Drug Targeting|September 22, 2012
Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signalingAkshay Pratap, Saurabh Singh, Vaibhav Mundra, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Plos One|November 9, 2013
Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantationVaibhav Mundra, Hao Wu, Ram I Mahato
Pharmaceutical Research|November 20, 2013
Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosisVirender Kumar, Vaibhav Mundra, Ram I Mahato
Nanomedicine (London, England)|August 6, 2015
Nanoparticle-mediated drug delivery for treating melanomaVaibhav Mundra, Wei Li, Ram I Mahato
Molecular Pharmaceutics|December 11, 2012
Mesenchymal stem cell-based therapyVaibhav Mundra, Ivan C Gerling, Ram I Mahato
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 21, 2015
Micellar formulation of indocyanine green for phototherapy of melanomaVaibhav Mundra, Yang Peng, Sandeep Rana, et al.
Clinical Pharmacology in Drug Development|September 3, 2025
Relative Bioavailability, Food Effect, and Bioequivalence Studies to Assess a New Zanubrutinib 160-mg Tablet: Results From 2 Phase 1 Studies in Healthy VolunteersBilal Tariq, Chester Lin, Vaibhav Mundra, et al.
Theranostics|August 22, 2018
Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing miceVirender Kumar, Vaibhav Mundra, Yang Peng, et al.
Drug Delivery and Translational Research|May 1, 2015
Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanomaVaibhav Mundra, Yang Peng, Virender Kumar, et al.
Pharmaceutical Research|October 12, 2012
Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agentVaibhav Mundra, Yan Lu, Michael Danquah, et al.
Journal of Drug Targeting|September 22, 2012
Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signalingAkshay Pratap, Saurabh Singh, Vaibhav Mundra, et al.
Pageof 2